Core A-GI Tissue Resource will coordinate histopathological assessment of all GI tissues collected from three local Tucson-area hospitals and existing banks of normal and neoplastic GI tissues. Approximately 700 colorectal, esophageal and pancreatic cancer patients are seen annually at the Arizona Cancer Center (ACC), the Southern Arizona Veterans Administration Medical Center (SAVAMC) and Tucson Medical Center (TMC). Existing tissue banks contain over 5000 frozen and fixed samples of normal intestinal tissues, more than 1500 colon adenomas and over 800 specimens from patients with Barrett?s esophagus have been collected and stored during the course of cancer prevention studies conducted at the ACC and SAVAMC. Standard methods of preservation and storing tissues will be employed to facilitate measurement of desired endpoints. Special services, such as laser capture microdissection, will be available. The activities of Core A-GI Tissue Resource will be coordinated with other proposed resources, to ensure collection of tissues from patients participating in the proposed clinical trials, standards of marker measurement in tissues, adequacy of statistical input into design of trials and evaluation of results from patient studies. With the assistance of Core E-Informatics, a comprehensive database for all samples within the GI Tissue Resource will be developed. This database will be designed so that it can be interrogated for patient related information, including outcome data, and specific prognostic and/or predictive factors obtained during the course of this research effort. Frozen and paraffin embedded tissue will be saved permanently. Prior to collection of tissue an informed consent will be procured. The consent will follow the guidelines established by National Action Plan on Breast Cancer (NAPBC) with approval and input from the Institutional Review Boards of the University Medical Center and the local participating hospitals. A Human Tissue Acquisition and Pathology Resource Committee, under the umbrella of the ACC, will be established to monitor this essential activity.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
1P50CA095060-01
Application #
6666181
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2002-09-05
Project End
2007-03-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Arizona
Department
Type
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85722
Goldenberg, Joshua M; Pagel, Mark D; Cárdenas-Rodríguez, Julio (2018) Characterization of D-maltose as a T2 -exchange contrast agent for dynamic contrast-enhanced MRI. Magn Reson Med 80:1158-1164
Jones, Kyle M; Pollard, Alyssa C; Pagel, Mark D (2018) Clinical applications of chemical exchange saturation transfer (CEST) MRI. J Magn Reson Imaging 47:11-27
Goldenberg, Joshua M; Cárdenas-Rodríguez, Julio; Pagel, Mark D (2018) Preliminary Results that Assess Metformin Treatment in a Preclinical Model of Pancreatic Cancer Using Simultaneous [18F]FDG PET and acidoCEST MRI. Mol Imaging Biol 20:575-583
Daryaei, Iman; Randtke, Edward A; Pagel, Mark D (2017) A biomarker-responsive T2exMRI contrast agent. Magn Reson Med 77:1665-1670
Daryaei, Iman; Jones, Kyle M; Pagel, Mark D (2017) Detection of DT-diaphorase Enzyme with a ParaCEST MRI Contrast Agent. Chemistry 23:6514-6517
Shkreta, Lulzim; Blanchette, Marco; Toutant, Johanne et al. (2017) Modulation of the splicing regulatory function of SRSF10 by a novel compound that impairs HIV-1 replication. Nucleic Acids Res 45:4051-4067
Kurzius-Spencer, Margaret; Harris, Robin B; Hartz, Vern et al. (2016) Relation of dietary inorganic arsenic to serum matrix metalloproteinase-9 (MMP-9) at different threshold concentrations of tap water arsenic. J Expo Sci Environ Epidemiol 26:445-51
Tsikitis, Vassiliki L; Potter, Amiee; Mori, Motomi et al. (2016) MicroRNA Signatures of Colonic Polyps on Screening and Histology. Cancer Prev Res (Phila) 9:942-949
Hingorani, Dina V; Montano, Luis A; Randtke, Edward A et al. (2016) A single diamagnetic catalyCEST MRI contrast agent that detects cathepsin B enzyme activity by using a ratio of two CEST signals. Contrast Media Mol Imaging 11:130-8
Fernández-Cuervo, Gabriela; Sinharay, Sanhita; Pagel, Mark D (2016) A CatalyCEST MRI Contrast Agent that Can Simultaneously Detect Two Enzyme Activities. Chembiochem 17:383-7

Showing the most recent 10 out of 239 publications